9 research outputs found
Contrasting changes of urban heat island intensity during hot weather episodes
Cities typically exhibit higher air temperatures than their rural surroundings, a phenomenon known as the urban heat island (UHI) effect. Contrasting results are reported as to whether UHI intensity (UHII) is exacerbated or reduced during hot weather episodes (HWEs). This contrast is investigated for a four-year period from 2015 to 2018, utilising a set of observational data from high-quality meteorological stations, as well as from hundreds of crowdsourced citizen weather stations, located in the urban region of Berlin, Germany. It can be shown that if HWEs, defined here as the ten percent hottest days or nights during MayâSeptember, are identified via daytime conditions, or by night-time conditions at inner-city sites, then night-time UHII is exacerbated. However, if HWEs are identified via night-time conditions at rural sites, then night-time UHII is reduced. These differences in UHII change can be linked with prevalent weather conditions, namely radiation, cloud cover, wind speed, precipitation, and humidity. This highlights that, beside land cover changes, future changes in weather conditions due to climate change will control UHIIs, and thus heat-stress hazards in cities.BMBF, 01LP1602C , Verbundprojekt Stadtklima: Dreidimensionale Beobachtung atmosphĂ€rischer Prozesse in StĂ€dten, Modul B - 3DODFG, 322579844, Hitzewellen in Berlin, Deutschland - StadtklimamodifkationenDFG, 414044773, Open Access Publizieren 2019 - 2020 / Technische UniversitĂ€t Berli
Comparison of MICs in Escherichia coli isolates from human health surveillance with MICs obtained for the same isolates by broth microdilution
Objectives
Human health surveillance and food safety monitoring systems use different antimicrobial susceptibility testing (AST) methods. In this study, we compared the MICs of Escherichia coli isolates provided by these methods.
Methods
E. coli isolates (n = 120) from human urine samples and their MICs were collected from six medical laboratories that used automated AST methods based on bacterial growth kinetic analyses. These isolates were retested using broth microdilution, which is used by the food safety monitoring system. The essential and categorical agreements (EA and CA), very major errors (VME), major errors (ME) and minor errors (mE) for these two methods were calculated for 11 antibiotics using broth microdilution as a reference. For statistical analysis, clinical breakpoints provided by EUCAST were used.
Results
Five study laboratories used VITEKÂź2 and one MicroScan (Walkaway Combo Panel). Out of 120 isolates, 118 isolates (98.3%) were confirmed as E. coli. The 99 E. coli isolates from five study laboratories that used VITEKÂź2 showed high proportions of EA and CA with full agreements for gentamicin, meropenem, imipenem and ertapenem. Additionally, 100% CA was also observed in cefepime. Few VME (0.5%), ME (1.9%) and mE (1.5%) were observed across all antibiotics. One VME for ceftazidime (7.1%) and 12 MEs for ampicillin (29.4%), cefotaxime (2.4%), ciprofloxacin (3.2%), tigecycline (1.5%) and trimethoprim (22.2%) were detected.
Conclusions
MICs from E. coli isolates produced by VITEKÂź2 were similar to those determined by broth microdilution. These results will be valuable for comparative analyses of resistance data from human health surveillance and food safety monitoring systems
Molecular characterisation of virulence graded field isolates of myxoma virus
<p>Abstract</p> <p>Background</p> <p><it>Myxoma virus </it>(MV) has been endemic in Europe since shortly after its deliberate release in France in 1952. While the emergence of more resistant hosts and more transmissible and attenuated virus is well documented, there have been relatively few studies focused on the sequence changes incurred by the virus as it has adapted to its new host. In order to identify regions of variability within the MV genome to be used for phylogenetic studies and to try to investigate causes of MV strain attenuation we have molecularly characterised nine strains of MV isolated in Spain between the years 1992 and 1995 from wide ranging geographic locations and which had been previously graded for virulence by experimental infection of rabbits.</p> <p>Results</p> <p>The findings reported here show the analysis of 16 genomic regions accounting for approximately 10% of the viral genomes. Of the 20 genes analysed 5 (M034L, M069L, M071L, M130R and M135R) were identical in all strains and 1 (M122R) contained only a single point mutation in an individual strain. Four genes (M002L/R, M009L, M036L and M017L) showed insertions or deletions that led to disruption of the ORFs.</p> <p>Conclusions</p> <p>The findings presented here provide valuable tools for strain differentiation and phylogenetic studies of MV isolates and some clues as to the reasons for virus attenuation in the field.</p
A B2C Marketing Plan for Darkglass Electronics in China
The objective of this thesis was to develop marketing suggestions for Darkglass Electronics in the Chinese market. The intention of the thesis was to research the Chinese market and the marketing channels used in China. Another intention was to carry out a situational analysis of Darkglass Electronics and their competitors.
The theoretical framework was based on literature about product marketing, marketing channels and buyer behaviour.
The study was carried out in the form of a digital questionnaire, which was sent to the representative of the company. The analytical approach was qualitative to ensure an in-depth understanding of the situation of the company. Furthermore, the study also involved intensive online research into the Chinese market.
The findings indicated that the company were not aware of the marketing channels available in China. This thesis worked to solve this issue and to provide suggestions on how to improve the companyâs current situation.
In conclusion, there is room for Darkglass Electronics to improve their marketing approach in China. By following the suggestions found within this report, the company will be able to develop their marketing strategy to be as effective and efficient as possible
Multicentre investigation of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in German hospitals
Aim of this study was to determine the incidence and molecular epidemiology of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in Germany. E. coli and K. pneumoniae isolates from clinical samples which were non-susceptible to carbapenems were collected in laboratories serving 20 hospitals throughout Germany from November 2013 to April 2014. The isolates were tested for the presence of carbapenemases by PCR and phenotypic methods and typed by multilocus sequence typing. Risk factors including a previous hospitalization abroad were analysed. Carbapenemases were detected in 24 isolates from 22 patients out of 464,514 admissions. Carbapenemases included OXA-48 (n=14), KPC-2 (n = 8) and NDM-1 (n =2). Except for two K. pneumoniae isolates with ST101, all OXA-48 producing strains belonged to different clones. In contrast, half of KPC-2 producing K. pneumoniae were of ST258 and both NDM-1 producing strains were of ST11. Compared to carbapenem-susceptible controls, patients with carbapenemase-producing strains differed by a significantly higher proportion of males, a higher proportion of isolates from wound samples and a more frequent previous stay abroad in univariate analysis. This multicentre study demonstrated an incidence of carbapenemase-producing E. coli and K. pneumoniae from clinical samples in Germany of 0.047 cases per 1000 admissions. OXA-48 was more frequent than KPC-2 and NDM-1 and showed a multiclonal background. (C) 2016 Elsevier GmbH. All rights reserved
Surface-water conditions in the Mediterranean Basin during earliest Pliocene as revealed by calcareous nannofossil assemblages: Comparison between western and eastern sectors
Evaluation of a quality improvement intervention to reduce anastomotic leak following right colectomy (EAGLE): pragmatic, batched stepped-wedge, cluster-randomized trial in 64 countries
Background
Anastomotic leak affects 8 per cent of patients after right colectomy with a 10-fold increased risk of postoperative death. The EAGLE study aimed to develop and test whether an international, standardized quality improvement intervention could reduce anastomotic leaks.
Methods
The internationally intended protocol, iteratively co-developed by a multistage Delphi process, comprised an online educational module introducing risk stratification, an intraoperative checklist, and harmonized surgical techniques. Clusters (hospital teams) were randomized to one of three arms with varied sequences of intervention/data collection by a derived stepped-wedge batch design (at least 18 hospital teams per batch). Patients were blinded to the study allocation. Low- and middle-income country enrolment was encouraged. The primary outcome (assessed by intention to treat) was anastomotic leak rate, and subgroup analyses by module completion (at least 80 per cent of surgeons, high engagement; less than 50 per cent, low engagement) were preplanned.
Results
A total 355 hospital teams registered, with 332 from 64 countries (39.2 per cent low and middle income) included in the final analysis. The online modules were completed by half of the surgeons (2143 of 4411). The primary analysis included 3039 of the 3268 patients recruited (206 patients had no anastomosis and 23 were lost to follow-up), with anastomotic leaks arising before and after the intervention in 10.1 and 9.6 per cent respectively (adjusted OR 0.87, 95 per cent c.i. 0.59 to 1.30; P = 0.498). The proportion of surgeons completing the educational modules was an influence: the leak rate decreased from 12.2 per cent (61 of 500) before intervention to 5.1 per cent (24 of 473) after intervention in high-engagement centres (adjusted OR 0.36, 0.20 to 0.64; P < 0.001), but this was not observed in low-engagement hospitals (8.3 per cent (59 of 714) and 13.8 per cent (61 of 443) respectively; adjusted OR 2.09, 1.31 to 3.31).
Conclusion
Completion of globally available digital training by engaged teams can alter anastomotic leak rates. Registration number: NCT04270721 (http://www.clinicaltrials.gov)